Nicholas Bacopoulos
Direttore/Membro del Consiglio presso MAKScientific LLC
Profilo
Nicholas G.
Bacopoulos is the founder of Medexis Biotech SA. He is currently the Director at MAKScientific LLC.
Previously, he served as the President & Chief Executive Officer at Mersana Therapeutics, Inc. and Aton Pharma, Inc. He was also the President & Chief Executive Officer at Anaderm Research Corp.
He served as an Independent Director at Cyclacel Pharmaceuticals, Inc. from 2008 to 2016.
He was a Director at Priaxon AG and Kotinos Pharmaceuticals, Inc. He served as the President & Head-Research & Development at OSI Pharmaceuticals, Inc. and as a Principal at Pfizer Central Research.
He was a Faculty Member at Dartmouth Medical School.
He completed his undergraduate degree at Cornell College (Iowa) and his doctorate at the University of Iowa.
Posizioni attive di Nicholas Bacopoulos
Società | Posizione | Inizio |
---|---|---|
MAKScientific LLC
MAKScientific LLC Pharmaceuticals: MajorHealth Technology MAKScientific LLC develops drugs to treat medical disorders by modulating the endocannabinoid system. The firm discovers medications for metabolic disorders, pain, addiction, and neurological diseases. The company was founded by Alexandros Makriyannis in 2004 and is headquartered in Mystic, CT. | Direttore/Membro del Consiglio | - |
Precedenti posizioni note di Nicholas Bacopoulos
Società | Posizione | Fine |
---|---|---|
CYCLACEL PHARMACEUTICALS, INC. | Direttore/Membro del Consiglio | 01/07/2016 |
Priaxon AG
Priaxon AG Miscellaneous Commercial ServicesCommercial Services Priaxon AG operates as a drug discovery company for small molecule therapeutics. The firm develops a platform PriaXplore that consists of several chemo informatics methods and concepts especially designed for the application in the field of identifying new potential inhibitors of protein protein interactions (PPI). The company was founded by Christoph Burdack in 2008 and is headquartered in Munich, Germany. | Direttore/Membro del Consiglio | - |
Dartmouth Medical School | Corporate Officer/Principal | - |
Anaderm Research Corp. | Amministratore Delegato | - |
PFIZER, INC. | Corporate Officer/Principal | - |
Formazione di Nicholas Bacopoulos
Cornell College (Iowa) | Undergraduate Degree |
University of Iowa | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 3 |
---|---|
CYCLACEL PHARMACEUTICALS, INC. | Health Technology |
MERSANA THERAPEUTICS, INC. | Health Technology |
PFIZER, INC. | Health Technology |
Aziende private | 7 |
---|---|
Aton Pharma, Inc.
Aton Pharma, Inc. Pharmaceuticals: MajorHealth Technology Aton Pharma, Inc. develops therapeutics for cancer and other diseases. Its products include Edecrin, Sodium Edecrin, Cuprimine, Demser and Syprine. The company was founded by Michael G. Wells in 2001 and is headquartered in Lawrenceville, NJ. | Health Technology |
Medexis Biotech SA | |
OSI Pharmaceuticals, Inc.
OSI Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology OSI Pharmaceuticals, Inc. manufactured and develope dpharmaceutical drugs. The company was founded in 1983 and was headquartered in Farmingdale, NY. | Health Technology |
Kotinos Pharmaceuticals, Inc. | |
Anaderm Research Corp. | |
Priaxon AG
Priaxon AG Miscellaneous Commercial ServicesCommercial Services Priaxon AG operates as a drug discovery company for small molecule therapeutics. The firm develops a platform PriaXplore that consists of several chemo informatics methods and concepts especially designed for the application in the field of identifying new potential inhibitors of protein protein interactions (PPI). The company was founded by Christoph Burdack in 2008 and is headquartered in Munich, Germany. | Commercial Services |
MAKScientific LLC
MAKScientific LLC Pharmaceuticals: MajorHealth Technology MAKScientific LLC develops drugs to treat medical disorders by modulating the endocannabinoid system. The firm discovers medications for metabolic disorders, pain, addiction, and neurological diseases. The company was founded by Alexandros Makriyannis in 2004 and is headquartered in Mystic, CT. | Health Technology |
- Borsa valori
- Insiders
- Nicholas Bacopoulos